FDA relents and will review Moderna's flu shot The FDA will start a review of Moderna's flu jab mRNA-1010, after refusing to accept the filing last week, with a new "regulatory approach."

#Moderna confirmed this morning that the #FDA has had a change of heart on the #marketingapplication for its #influenzavaccine mRNA-1010, and will now start a #review.

pharmaphorum.com/news/fda-rel...